EUVIMEDEUVIMED entdecken
Crossref

Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy

Fangfang Cao, Lulu Jin, Chenyin Zhang, Yong Gao, Zhefeng Qian, Hongyang Wen, Sisi Yang, Ziqiang Ye, Liangjie Hong, Huang Yang, Zongrui Tong, Liang Cheng und 5 weitere

Advanced Materials · 2024-02 · 36 (5)

DOI: 10.1002/adma.202304257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 04.12.2023. Verfasst von Fangfang Cao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Diagnostic Radiology Surgery Chemical and Biomolecular Engineering and Biomedical Engineering, Yong Loo Lin School of Medicine and Col…. Hauptthemen laut MEDLINE: Probiotics, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Zhejiang Province, Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotics have the potential as biotherapeutic agents for cancer management in preclinical models and human trials by secreting antineoplastic or immunoregulatory agents in the tumor microenvironment (TME). However, current probiotics lack the ability to dynamically respond to unique TME characteristics, leading to limited therapeutic accuracy and efficacy. Although progress has been made in customizing controllable probiotics through synthetic biology, the engineering process is complex and the predictability of production is relatively low. To address this, here, for the first time, this work adopts pH‐dependent peroxidase‐like (POD‐like) artificial enzymes as both an inducible “nano‐promoter” and “nano‐effector” to engineer clinically relevant probiotics to achieve switchable control of probiotic therapy. The nanozyme initially serves as an inducible “nano‐promoter,” generating trace amounts of nonlethal reactive oxygen species (ROS) stress to upregulate acidic metabolites in probiotics. Once metabolites acidify the TME to a threshold, the nanozyme switches to a “nano‐effector,” producing a great deal of lethal ROS to fight cancer. This approach shows promise in subcutaneous, orthotopic, and colitis‐associated colorectal cancer tumors, offering a new methodology for modulating probiotic metabolism in a pathological environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsNeoplasmsAntineoplastic AgentsHumansReactive Oxygen SpeciesTumor Microenvironment

Stichwörter der Autor:innen

artificial enzymescolorectal cancermetabolic regulationnano-effectorsnano-promoterprobiotics

Substanzen

Reactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Departments of Diagnostic Radiology Surgery Chemical and Biomolecular Engineering and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Sing…
  • Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
  • Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou, 310009, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Di…
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon Based Functional Materials & Devices, Soochow University, Suzhou, 215123, China.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Zhejiang Province
  • Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
  • Zhejiang High-Level Young Talent Special Support Plan
  • National University of Singapore
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation

Zitieren

APA

Cao, F., Jin, L., Zhang, C., Gao, Y., Qian, Z., Wen, H., Yang, S., Ye, Z., Hong, L., Yang, H., Tong, Z., Cheng, L., Ding, Y., Wang, W., Yu, G., Mao, Z., & Chen, X. (2024). Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy. Advanced Materials, 36(5). https://doi.org/10.1002/adma.202304257

Vancouver

Cao F, Jin L, Zhang C, Gao Y, Qian Z, Wen H, et al. Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy. Advanced Materials. 2024;36(5). doi:10.1002/adma.202304257

BibTeX
@article{Cao2024,
  author = {Cao, Fangfang and Jin, Lulu and Zhang, Chenyin and Gao, Yong and Qian, Zhefeng and Wen, Hongyang and Yang, Sisi and Ye, Ziqiang and Hong, Liangjie and Yang, Huang and Tong, Zongrui and Cheng, Liang and Ding, Yuan and Wang, Weilin and Yu, Guocan and Mao, Zhengwei and Chen, Xiaoyuan},
  title = {Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {5},
  doi = {10.1002/adma.202304257}
}
Kostenlos starten →